tirzepatide is for what The promise of tirzepatide: A narrative review of metabolic benefits What Is Tirzepatide? How It

In these participants, concentrations of latent myostatin, a pharmacodynamic marker, increased substantially after the first dose, achieved a plateau at approximately week 16 and remained consistently elevated throughout the treatment period, demonstrating successful target engagement (Extended Data Fig

The main consideration is gastrointestinal tolerance: both drugs can cause nausea, diarrhea, or abdominal discomfort, particularly in the first 24 weeks of semaglutide initiation

if confirmed, semaglutide should not be restarted

Dosing errors are unlikely to cause serious harm

doi:10.1210/jc.2004-1719 Berlanga-Acosta J, Abreu-Cruz A, Herrera DGB, et al

That confusion is common because semaglutide began as a diabetes drug before becoming widely known for weight management